Characteristics of Incident Testicular Cancer in Lebanon - 1990-2015 Single Institutional Experience

  • Assi, Tarek ;
  • Nasr, Fadi ;
  • El Rassy, Elie ;
  • Ibrahim, Toni ;
  • Jabbour, Hicham ;
  • Chahine, Georges
  • Published : 2016.06.01


Background: Despite the fact that testicular cancer is a major health issue with its increasing incidence, very few studies have described its characteristics in the Middle East, particularly in Lebanon. Materials and Methods: We report in this paper a retrospective pilot study of the characteristics of testicular cancer in Lebanon. The demographic, epidemiologic and survival characteristics of 178 patients diagnosed between 1990 and 2015 at an oncology clinic affiliated to Hotel Dieu de France Hospital were analyzed. Results: The mean age at diagnosis was $32{\pm}10years$. The most prevalent testicular tumor was the germ cell type (GCT) (95.2%) of which non-seminomatous tumors (NST) were the commonest (64.7%). Most of our patients were diagnosed at an early stage. Lymph node spread affected most commonly the retroperitoneal region and distant visceral metastases occurred in 14.6%. All patients underwent orchiectomy with 67% receiving adjuvant treatment, mainly chemotherapy. After a median follow up of 2,248 days (75.9 months) 16 patients were reported dead. Two, five and ten-year overall survival rates were 96%, 94% and 89% respectively. The median overall survival rate was not reached. Conclusions: Despite being part of the developing world, demographic, epidemiologic and survival analyses of testicular cancer reported in our study are in line with those reported from developed countries and would allow us to extrapolate management plans from these populations.


Epidemiology;survival;testicular cancer;Lebanon;Middle East


  1. Assi T., Rassy M, Nassereddine H, et al (2015). Distribution of testicular tumors in Lebanon: a single institution overview. Asian Pac. J. Cancer Prev, 16, 3443-6.
  2. Barbour, B., Salameh, P. (2009). Consanguinity in Lebanon: prevalence, distribution and determinants. J Biosoc Sci, 41, 505-17.
  3. Chahine G, El Rassy E, Khazzaka, et al (2015). Characteristics of incident female breast cancer in Lebanon, 1990-2013: Descriptive study of 612 cases from a hospital tumor registry. Cancer Epidemiol, 39, 303-6.
  4. Chalya PL, Simbila S, Rambau PF, et al (2014). Ten-year experience with testicular cancer at a tertiary care hospital in a resource-limited setting: a single centre experience in Tanzania. World J Surg Oncol, 12, 1-8.
  5. Chia VM, Quraishi SM, Devesa SS, (2010). International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomark Prev, 19, 1151-9.
  6. Ferguson L, Agoulnik AI, (2013). Testicular cancer and cryptorchidism. Front Endocrinol, 4, 32.
  7. Fleming ID, Cooper JS, Henson DE, et al (1997). AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven.
  8. Fritz A, Percy C, Jack A, et al (2000). International classification of diseases foroncology. 3rd ed Geneva: World Health Organization.
  9. Garner MJ, Turner MC, Ghadirian P, et al (2005). Epidemiology of testicular cancer: An overview. Int J Cancer, 116, 331-9.
  10. Lip SZL, Murchison LED, Cullis PS, et al (2013). A metaanalysis of the risk of boys with isolated cryptorchidism developing testicular cancer in later life. Arch Dis Child, 98, 20-26.
  11. Moreno, A., Domínguez, A., Alpuente, C., et al (2015). Clinical presentation features of testicular cancer in public hospitals in the Autonomous Community of Madrid, Spain. Actas Urol Esp Engl, 39, 2-7.
  12. Nigam, M., Aschebrook-Kilfoy, B., Shikanov, S., et al (2015). Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009. World J Urol. 33, 623-31.
  13. Power DA, Brown RS, Brock, et al (2001). Trends in testicular carcinoma in England and Wales, 1971-99. BJU Int, 87, 361-5.
  14. Saab M, Noureddine S, Abu-Saad Huijer H, et al (2014). Surviving testicular cancer: the Lebanese lived experience. Nurs Res, 63, 203-10.
  15. Sant M, Aareleid T, Artioli ME, et al (2007). Ten-year survival and risk of relapse for testicular cancer: A EUROCARE high resolution study. Eur. J. Cancer, 43, 585-592.
  16. SEER Cancer Statistics Factsheets: Testis Cancer. National Cancer Institute. Bethesda, MD,, n.d.
  17. Trabert B, Chen J, Devesa SS, et al (2015). International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007. Androl, 3, 4-12.